文献速递鼻科

特应性在慢性鼻窦炎中的影响:对生活质量结局的作用

Atopy in chronic rhinosinusitis: impact on quality of life outcomes.
PubMed 文献 · Int Forum Allergy Rhinol · 2019-01-03

横断面研究纳入446例接受内镜鼻窦手术的成人慢性鼻窦炎患者,以特异性IgE阳性或总IgE>160 kU/L定义特应性。特应性与鼻部症状评分更高及嗅觉/味觉丧失、需擤鼻问题更差相关,但在鼻息肉亚组中特应性与患者报告结局无显著关联。作者认为特应性评估对确保恰当成功治疗重要。

要点

  • 特应性与更年轻的鼻窦手术年龄、鼻息肉、哮喘及嗜酸性慢性鼻窦炎相关。
  • 特应性患者鼻症状评分更高(13.1±6.4 vs 11.9±6.0,p=0.04)。
  • 鼻息肉亚组中特应性与患者报告结局无显著关联。

核心结论

  • 慢性鼻窦炎合并特应性与额外症状负担相关,主要体现在鼻部症状生活质量指标上。
  • 作者认为慢性鼻窦炎中的特应性评估对确保恰当且成功的治疗是重要的。

研究设计与样本

  • 横断面研究,纳入接受内镜鼻窦手术的成人慢性鼻窦炎患者446例。
  • 特应性定义为特异性IgE阳性或总IgE>160 kU/L。
  • 采用22项鼻窦结局测试(SNOT-22)评估患者报告结局。

主要发现

  • 446例中女性占45.7%,年龄49.05±14.96岁;哮喘占42.8%,慢性鼻窦炎伴鼻息肉占51.6%,嗜酸性慢性鼻窦炎占63.0%。
  • 过敏原致敏阳性者占52.9%;总IgE升高者占28.0%,平均IgE水平161±269 kU/L。
  • 特应性与更年轻的鼻窦手术年龄、慢性鼻窦炎伴鼻息肉、哮喘及嗜酸性慢性鼻窦炎相关。
  • 特应性与鼻症状评分更高相关(13.1±6.4 vs 11.9±6.0,p=0.04)。
  • 特应性与嗅觉/味觉丧失问题(χ2(1)=5.97,p=0.02)及需擤鼻问题(χ2(1)=4.26,p=0.04)评分更差相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Chronic rhinosinusitis (CRS), in particular with nasal polyps (CRSwNP), has been linked with skewed T-helper 2 and immunoglobulin E (IgE)-mediated allergic responses. The role of atopy in CRS, however, remains unclear. Correlations between immunological allergic markers and patient-reported outcomes measures (PROMs) were investigated. METHODS: A cross-sectional study of adult patients with CRS undergoing endoscopic sinus surgery was conducted. Immunological allergic markers included automated immunoassay testing for serum-specific IgE to common allergens (house dust mite, grass, mold, animal epithelia) and total IgE. PROMs were assessed using the 22-item Sino-Nasal Outcome Test (SNOT-22). Patients were defined as atopic based on either a positive specific IgE or elevated total IgE (>160 kU/L). RESULTS: A total of 446 patients (45.7% female, age 49.05 ± 14.96 years) were recruited, of which 42.8% had asthma, 51.6% had CRSwNP, and 63.0% had eosinophilic CRS. Positive allergen sensitization was detected in 52.9% patients. Total IgE levels were elevated in 28.0% with mean IgE level of 161 ± 269 kU/L. Atopy was associated with younger age at the time of surgery, CRSwNP, asthma, and eosinophilic CRS (eCRS). Atopy was also associated with increased severity in nasal symptom score (13.1 ± 6.4 vs 11.9 ± 6.0, p = 0.04), as well as worse scores in the loss of smell/taste (χ2 (1) = 5.97, p = 0.02) and need to blow nose (χ2 (1) = 4.26, p = 0.04) questions in the CRS population. In the CRSwNP population, there was no significant association between atopy and PROMs. CONCLUSION: Comorbid atopy in CRS is associated with additional symptom burden, reflected mainly within the nasal symptom quality of life markers. Atopy assessment in CRS is important to ensure appropriate and successful treatment of the disease.

来源:Int Forum Allergy Rhinol,查看原文。版权归原作者所有。

引用

  1. Ho J, Alvarado R, Rimmer J, et al. Atopy in chronic rhinosinusitis: impact on quality of life outcomes. Int Forum Allergy Rhinol. 2019. PMID: 30604578. doi:10.1002/alr.22272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。